4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow KLH-2109: new trials by email Literature Review of KLH-2109 trials Research Report on KLH-2109
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis KLH-2109, Placebo, Leuprorelin acetate - Endometriosis | Phase 2 | Completed | Kissei Pharmaceutical Co., Ltd. | 2016-05-09 | 2019-06-04 | |
| A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1) KLH-2109 - Endometriosis | Phase 2 | Completed | Kissei Pharmaceutical Co., Ltd. | 20 | 2013-10-30 | |
| A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2) KLH-2109, placebo - Endometriosis | Phase 2 | Completed | Kissei Pharmaceutical Co., Ltd. | 100 | 2014-05-30 | |
| A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis KLH-2109 - Endometriosis | Phase 2 | Completed | Kissei Pharmaceutical Co., Ltd. | 20 | 2014-05-30 |
Endometriosis (4)
Kissei Pharmaceutical Co., Ltd. (4)
Japan (4)
Katsumi Hontani (1) · Tatsuro Takei (1)